FDA Clears Sentient’s Tixel for Treatment of Periorbital Wrinkles
Sentient announces that the U.S. Food and Drug Administration has approved Tixel by Sentient, its non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles.
Sentient announces that the U.S. Food and Drug Administration has approved Tixel by Sentient, its non-invasive skin resurfacing technology, for the treatment of periorbital wrinkles.
Researchers have discovered a naturally occurring protein that could lead to new therapies for preventing excessive scarring in patients during wound healing.